{"mainPropery":{"diseaseId":6675,"diseaseName":"Mucopolysaccharidosis type II","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/6675/mucopolysaccharidosis-type-ii","synonyms":["MPS II","Attenuated MPS (subtype; formerly known as mild MPS II)","Severe MPS II","Hunter syndrome","Iduronate 2-sulfatase deficiency","I2S deficiency","MPS 2"],"synonyms-with-source":[{"name":"MPS II"},{"name":"Attenuated MPS (subtype; formerly known as mild MPS II)"},{"name":"Severe MPS II"},{"name":"Hunter syndrome"},{"name":"Iduronate 2-sulfatase deficiency"},{"name":"I2S deficiency"},{"name":"MPS 2"}],"identifiers":[{"identifierType":"OMIM","identifierId":"309900"},{"identifierType":"ORPHANET","identifierId":"580"}]},"diseaseCategories":[{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"}],"organizations":[{"resourceID":37,"resourceName":"Canadian Society for Mucopolysaccharide and Related Diseases Inc. (Canadian MPS Society)","abbreviation":"","address1":"#218-2055 Commercial Drive ","address2":"Vancouver, BC V5N OC7","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"Canada","phone":"604-924-5130","tty":"","tollFree":"800-667-1846","fax":"604-924-5131","email":"info@mpssociety.ca","url":"http://www.mpssociety.ca","freeText":""},{"resourceID":209,"resourceName":"National MPS Society","abbreviation":"","address1":"P.O. Box 14686 ","address2":"","address3":"","address4":"","address5":"","city":"Durham","state":"NC","zip":"27709-4686","country":"United States","phone":"+1-919-806-0101","tty":"","tollFree":"1-877-MPS-1001 (1-877-677-1001)","fax":"+1-919-806-2055","email":"info@mpssociety.org","url":"https://mpssociety.org/","freeText":""},{"resourceID":210,"resourceName":"Society for Mucopolysaccharide (MPS) Diseases","abbreviation":"","address1":"MPS House Repton Place White Lion Road","address2":"Amersham Buckinghamshire","address3":"HP7 9LP","address4":"","address5":"","city":"","state":"","zip":"","country":"United Kingdom","phone":"(+44) 0345 389 9901 ","tty":"","tollFree":"","fax":"","email":"mps@mpssociety.co.uk","url":"http://www.mpssociety.co.uk","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/309900' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?itool=omim_Detailed&db=omim&cmd=Display&dopt=omim_pubmed_calculated&from_uid=309900' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Mucopolysaccharidosis type II. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Mucopolysaccharidosis+type+II%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Mucopolysaccharidosis type II. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='https://ghr.nlm.nih.gov/condition/mucopolysaccharidosis' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Mucopolysaccharidosis type II. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":267,"resourceId":1104,"resourceName":"American Society of Gene & Cell Therapy -Disease treatment","descriptionText":"The <a href='https://www.asgct.org/education' target='_blank'>American Society of Gene &amp; Cell Therapy</a> provides information on the treatment of genetic diseases.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":869,"resourceId":1575,"resourceName":"RDCRN - Lysosomal Disease Network","descriptionText":"The&nbsp;<a href='https://www.rarediseasesnetwork.org/ldn' target='_blank'>Lysosomal Disease Network</a>&nbsp;is a team of doctors, nurses, research coordinators, and research labs throughout the U.S., working together to improve the lives of people with this condition through research. The&nbsp;Lysosomal Disease Network&nbsp;has a registry for patients who wish to be contacted about clinical research opportunities.<br />","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/282/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1529,"resourceId":2128,"resourceName":"MedlinePlus","descriptionText":"<a href='http://www.nlm.nih.gov/medlineplus/ency/article/001203.htm' target='_blank'>MedlinePlus</a> was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.\r\n<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1530,"resourceId":2161,"resourceName":"National Institute of Neurological Disorders and Stroke (NINDS)","descriptionText":"The <a href='https://www.ninds.nih.gov/Disorders/All-Disorders/Mucopolysaccharidoses-Information-Page' target='_blank'>National Institute of Neurological Disorders and Stroke</a> (NINDS) collects and disseminates research information related to neurological disorders. Click on the link to view information on&nbsp;this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://www.emedicine.com/ped/TOPIC1029.HTM' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1532,"resourceId":2163,"resourceName":"Social Security Administration","descriptionText":"The <a href='https://secure.ssa.gov/apps10/poms.nsf/lnx/0423022410' target='_blank'>Social Security Administration</a> has included this condition in their Compassionate Allowances Initiative. This initiative speeds up the processing of disability claims for applicants with certain medical conditions that cause severe disability. More information about <a href=\"http://www.ssa.gov/compassionateallowances/index.htm\" target=\"_blank\">Compassionate Allowances</a> and <a href=\"https://www.ssa.gov/benefits/disability/\" target=\"_blank\">applying for Social Security disability</a> is available online.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=580' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=hunter' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1705,"resourceId":2846,"resourceName":"Project OrphanAnesthesia","descriptionText":"<a href='http://www.orphananesthesia.eu/en/rare-diseases/published-guidelines/cat_view/61-rare-diseases/60-published-guidelines/112-hunter-syndrome.html' target='_blank'>Project OrphanAnesthesia</a> is a project whose aim is to create peer-reviewed, readily accessible guidelines for patients with rare diseases and for the anesthesiologists caring for them. The project is a collaborative effort of the German Society of Anesthesiology and Intensive Care, Orphanet, the European Society of Pediatric Anesthesia, anesthetists and rare disease experts with the aim to contribute to patient safety.","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:309900' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2158,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"<a href='https://rarediseases.org/for-patients-and-families/help-access-medications/patient-assistance-programs-2/' target='_blank'>National Organization for Rare Disorders</a> (NORD) has Disease-Specific Assistance Programs designed to help patients with out-of-pocket costs such as monthly insurance premiums or deductibles. In addition, some programs may provide financial assistance for additional expenses related to a patient's diagnosis such as travel to see a specialist.","resourceClassificationName":"Living With","resourceClassificationSectionName":"Financial Resources"}],"overviewQuestion":{"questionId":918,"questionText":"What is mucopolysaccharidosis II (MPS II)?","answerText":"<strong>Mucopolysaccharidosis II (MPS II)</strong>&nbsp;is an inherited disorder of carbohydrate metabolism that occurs almost exclusively in males. It is characterized by distinctive facial features, a&nbsp;large head, &nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/hydrocephalus.html\" target=\"_blank\">hydrocephalus</a>, enlargement of the liver and spleen (hepatosplenomegaly), umbilical or inguinal <a href=\"http://www.nlm.nih.gov/medlineplus/hernia.html\" target=\"_blank\">hernia</a>, and hearing loss.&nbsp;Individuals with this condition may additionally have joint deformities and&nbsp;heart abnormalities involving the valves. MPS II is caused by <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>  in the <em><a href=\"https://ghr.nlm.nih.gov/gene/IDS\" target=\"_blank\">IDS</a></em> <a href=\"http://ghr.nlm.nih.gov/handbook/basics/gene\" target=\"_blank\">gene</a>&nbsp;and is inherited in an <a href=\"http://www.genome.gov/Glossary/index.cfm?id=209\" target=\"_blank\">X-linked</a>  manner.[562] <br />\r\n<br />\r\nThere is a wide range in severity of symptoms present in individuals with MPS II. Previously, MPS II was classified as severe and attenuated based on severity. More recently, the terms slowly progressive and early progressive have been suggested. While both types affect many different parts of the body, people with&nbsp;the severe type&nbsp;also experience a decline in intellectual function and a more rapid disease progression. The life expectancy for people with the severe type&nbsp;is 10 to 20 years. Individuals with the less severe type typically live into adulthood and intelligence is not affected. Treatment is focused on managing the signs and symptoms present in each individual.[562][950]","dateModified":"2016-06-20T00:00:00"},"basicQuestions":[{"questionId":919,"questionText":"How is mucopolysaccharidosis II (MPS II) inherited?","answerText":"MPS II is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002051.htm\" target=_blank>X-linked recessive</a> pattern, which means that this conditions occurs almost exclusively in males. Females are generally unaffected carriers of this condition.&nbsp;In a family with more than one affected individual, the mother of the affected males must be a carrier. When a carrier female has a child, there is a 25% (1 in&nbsp;4)&nbsp;chance that she will have a affected son.[562]","dateModified":"2013-09-20T16:29:00","resourceClassificationName":"Inheritance","references":[{"referenceId":562,"authors":"Martin RA","articleTitle":"Mucopolysaccharidosis Type II","bookWebsiteJournalTitle":"Gene Reviews","date":"March 26, 2015","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=hunter","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":920,"questionText":"Is carrier testing for&nbsp;mucopolysaccharidosis II&nbsp;(MPS II) available?","answerText":"Yes, carrier testing for MPS II is available. Testing usually begins with&nbsp;an affected male relative, if one is&nbsp;available for testing, to determine the disease-causing mutation.&nbsp;If&nbsp;there is not living affected male relative,&nbsp;testing possible female carriers involves a type of <a href=\"http://ghr.nlm.nih.gov/handbook/testing/genetictesting\" target=_blank>genetic testing</a> called sequence analysis. This test requires a small blood sample and reads through the genetic code of the IDS gene looking for errors. If a mutation is not found using sequence analysis, then two other tests can be performed to look for mutations that cause MPS II. Genetic testing detects most of the mutations that cause MPS II, but may not detect all mutations that cause this condition&nbsp; Therefore, testing cannot definitively determine that a person is not a carrier for MPS II.[562] \r\n<p>The <a href=\"http://www.ncbi.nlm.nih.gov/gtr/\" target=_blank>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. Click <a href=\"http://www.ncbi.nlm.nih.gov/gtr/tests/?term=C0026705[DISCUI]&amp;condition=C0026705&amp;addition_svc=Carrier testing&amp;compare_labs=1&amp;sort_by=Alphabetical\" target=_blank>here</a> to link directly to a list of labs conducting carrier screening for MPS II. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional. </p>\r\n<p><em></em>&nbsp;</p>","dateModified":"2013-09-20T16:42:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":562,"authors":"Martin RA","articleTitle":"Mucopolysaccharidosis Type II","bookWebsiteJournalTitle":"Gene Reviews","date":"March 26, 2015","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=hunter","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":7065,"relatedDiseaseName":"Mucopolysaccharidosis","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[{"caseId":22046,"abbreviatedInquiry":"I had two brothers with the severe form of Hunter syndrome&nbsp;and both have passed away.&nbsp; I was never tested&nbsp;to see if I am a carrier, and now my daughter would like to&nbsp;know if she is a carrier.&nbsp;Is there a definitive test to determine if one is a&nbsp;carrier?&nbsp;Who do we contact to be tested?","caseQuestions":[{"questionId":918,"questionText":"What is mucopolysaccharidosis II (MPS II)?","answerText":"<strong>Mucopolysaccharidosis II (MPS II)</strong>&nbsp;is an inherited disorder of carbohydrate metabolism that occurs almost exclusively in males. It is characterized by distinctive facial features, a&nbsp;large head, &nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/hydrocephalus.html\" target=\"_blank\">hydrocephalus</a>, enlargement of the liver and spleen (hepatosplenomegaly), umbilical or inguinal <a href=\"http://www.nlm.nih.gov/medlineplus/hernia.html\" target=\"_blank\">hernia</a>, and hearing loss.&nbsp;Individuals with this condition may additionally have joint deformities and&nbsp;heart abnormalities involving the valves. MPS II is caused by <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>  in the <em><a href=\"https://ghr.nlm.nih.gov/gene/IDS\" target=\"_blank\">IDS</a></em> <a href=\"http://ghr.nlm.nih.gov/handbook/basics/gene\" target=\"_blank\">gene</a>&nbsp;and is inherited in an <a href=\"http://www.genome.gov/Glossary/index.cfm?id=209\" target=\"_blank\">X-linked</a>  manner.[562] <br />\r\n<br />\r\nThere is a wide range in severity of symptoms present in individuals with MPS II. Previously, MPS II was classified as severe and attenuated based on severity. More recently, the terms slowly progressive and early progressive have been suggested. While both types affect many different parts of the body, people with&nbsp;the severe type&nbsp;also experience a decline in intellectual function and a more rapid disease progression. The life expectancy for people with the severe type&nbsp;is 10 to 20 years. Individuals with the less severe type typically live into adulthood and intelligence is not affected. Treatment is focused on managing the signs and symptoms present in each individual.[562][950]","dateModified":"2016-06-20T00:00:00","references":[{"referenceId":562,"authors":"Martin RA","articleTitle":"Mucopolysaccharidosis Type II","bookWebsiteJournalTitle":"Gene Reviews","date":"March 26, 2015","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=hunter","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":950,"authors":"","articleTitle":"Mucopolysaccharidoses Fact Sheet","bookWebsiteJournalTitle":"National Institute of Neurological Disorders and Stroke (NINDS)","date":"February 23, 2016","volume":"","pages":"","url":"https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Mucopolysaccharidoses-Fact-Sheet","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":919,"questionText":"How is mucopolysaccharidosis II (MPS II) inherited?","answerText":"MPS II is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002051.htm\" target=_blank>X-linked recessive</a> pattern, which means that this conditions occurs almost exclusively in males. Females are generally unaffected carriers of this condition.&nbsp;In a family with more than one affected individual, the mother of the affected males must be a carrier. When a carrier female has a child, there is a 25% (1 in&nbsp;4)&nbsp;chance that she will have a affected son.[562]","dateModified":"2013-09-20T16:29:00","resourceClassificationName":"Inheritance","references":[{"referenceId":562,"authors":"Martin RA","articleTitle":"Mucopolysaccharidosis Type II","bookWebsiteJournalTitle":"Gene Reviews","date":"March 26, 2015","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=hunter","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":920,"questionText":"Is carrier testing for&nbsp;mucopolysaccharidosis II&nbsp;(MPS II) available?","answerText":"Yes, carrier testing for MPS II is available. Testing usually begins with&nbsp;an affected male relative, if one is&nbsp;available for testing, to determine the disease-causing mutation.&nbsp;If&nbsp;there is not living affected male relative,&nbsp;testing possible female carriers involves a type of <a href=\"http://ghr.nlm.nih.gov/handbook/testing/genetictesting\" target=_blank>genetic testing</a> called sequence analysis. This test requires a small blood sample and reads through the genetic code of the IDS gene looking for errors. If a mutation is not found using sequence analysis, then two other tests can be performed to look for mutations that cause MPS II. Genetic testing detects most of the mutations that cause MPS II, but may not detect all mutations that cause this condition&nbsp; Therefore, testing cannot definitively determine that a person is not a carrier for MPS II.[562] \r\n<p>The <a href=\"http://www.ncbi.nlm.nih.gov/gtr/\" target=_blank>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. Click <a href=\"http://www.ncbi.nlm.nih.gov/gtr/tests/?term=C0026705[DISCUI]&amp;condition=C0026705&amp;addition_svc=Carrier testing&amp;compare_labs=1&amp;sort_by=Alphabetical\" target=_blank>here</a> to link directly to a list of labs conducting carrier screening for MPS II. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional. </p>\r\n<p><em></em>&nbsp;</p>","dateModified":"2013-09-20T16:42:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":562,"authors":"Martin RA","articleTitle":"Mucopolysaccharidosis Type II","bookWebsiteJournalTitle":"Gene Reviews","date":"March 26, 2015","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=hunter","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":921,"questionText":"Who can I contact to learn more about genetic testing for mucopolysaccharidosis II (MPS II)?<br>","answerText":"We recommend that you contact a genetics clinic to learn more about carrier testing for MPS II. To find a genetics clinic near you, we recommend contacting your primary doctor for a referral. \r\n<p>The following online resources can also help you find a genetics professional in your community: <br></p>\r\n<ul>\r\n<li><a href=\"http://www.genetests.org/by-clinic/\" target=_blank>GeneTests</a> offers a searchable directory of U.S. and international genetics and prenatal diagnosis clinics.</li>\r\n<li>The <a href=\"http://www.nsgc.org/FindaGeneticCounselor/tabid/64/Default.aspx\" target=_blank>National Society of Genetic Counselors</a> provides a database of genetics counseling services, searchable by location, name, institution, type of practice, or specialty. </li>\r\n<li>The <a href=\"http://www.kumc.edu/gec/prof/genecntr.html\" target=_blank>University of Kansas Medical Center </a>provides a list of links to genetic centers and clinics, associations, and university genetics departments.</li>\r\n<li>The <a href=\"http://www.acmg.net/GIS/Default.aspx\" target=_blank>American College of Medical Genetics</a> has a Genetics Clinics Database for individuals who wish to locate a U.S. genetics center.</li>\r\n<li>The <a href=\"http://www.ashg.org/pages/member_search.shtml\" target=_blank>American Society of Human Genetics (ASHG)</a> is a professional organization of researchers and clinical geneticists. The ASHG maintains a database of its members, some of whom live outside of the United States. Visit the ASHG site if you are interested in obtaining a list of the geneticists in your country, though some may be researchers only and may not offer medical care. </li></ul>\r\n<p>You can also contact the MPS Society for more information on this condition and genetic testing.</p>\r\n<p>National Mucopolysaccharidoses/Mucolipidoses Society (MPS), Inc<br>National MPS Society<br>4220 NC Hwy 55, Ste.140<br>Durham, NC 27713<br>Toll-free: 877-MPS-1001<br>Phone: 919-806-0101<br>Fax: 919-806-2055<br>Email: <a href=\"mailto:http://www.mpssociety.org\">info@mpssociety.org </a><br>Web site: <a href=\"http://www.mpssociety.org/\" target=_blank>http://www.mpssociety.org</a></p>","dateModified":"2013-09-20T17:08:00","references":[]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":9878,"phenoTypeName":"Coarse facial features","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":5675,"phenoTypeName":"Limitation of joint mobility","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":9851,"phenoTypeName":"Macrocephaly","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":3605,"phenoTypeName":"Short stature","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13420,"phenoTypeName":"Chronic diarrhea","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11335,"phenoTypeName":"Conductive hearing impairment","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9929,"phenoTypeName":"Contractures of the large joints","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14146,"phenoTypeName":"Decreased nerve conduction velocity","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5154,"phenoTypeName":"Developmental regression","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10270,"phenoTypeName":"Dysostosis multiplex","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":2336,"phenoTypeName":"Enlarged tonsils","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":2647,"phenoTypeName":"Flexion contracture of digit","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9893,"phenoTypeName":"Full cheeks","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14208,"phenoTypeName":"Gingival overgrowth","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":8115,"phenoTypeName":"Hepatomegaly","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4766,"phenoTypeName":"Hoarse voice","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":6359,"phenoTypeName":"Inguinal hernia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10766,"phenoTypeName":"Irregularity of vertebral bodies","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9753,"phenoTypeName":"Macroglossia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14429,"phenoTypeName":"Peripheral visual field loss","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11425,"phenoTypeName":"Progressive neurologic deterioration","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":1168,"phenoTypeName":"Recurrent ear infections","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":7888,"phenoTypeName":"Recurrent upper respiratory tract infections","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5653,"phenoTypeName":"Retinal degeneration","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":10492,"phenoTypeName":"Retinopathy","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11337,"phenoTypeName":"Sensorineural hearing impairment","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":14130,"phenoTypeName":"Short attention span","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":11087,"phenoTypeName":"Sleep apnea","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4470,"phenoTypeName":"Sleep-wake cycle disturbance","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":3886,"phenoTypeName":"Splenomegaly","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":15422,"phenoTypeName":"Thick vermilion border","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4092,"phenoTypeName":"Umbilical hernia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9005,"phenoTypeName":"Abnormal aortic morphology","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":2796,"phenoTypeName":"Abnormal epiphyseal ossification","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10501,"phenoTypeName":"Abnormal foveal morphology","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":12786,"phenoTypeName":"Abnormal full-field electroretinogram","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4776,"phenoTypeName":"Abnormal mitral valve morphology","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14384,"phenoTypeName":"Abnormal nasal mucus secretion","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8972,"phenoTypeName":"Abnormal pulmonary valve morphology","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":3853,"phenoTypeName":"Abnormal tricuspid valve morphology","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10564,"phenoTypeName":"Abnormality of retinal pigmentation","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4782,"phenoTypeName":"Cardiomyopathy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9422,"phenoTypeName":"Communicating hydrocephalus","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4887,"phenoTypeName":"Constrictive median neuropathy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14402,"phenoTypeName":"Corneal opacity","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8723,"phenoTypeName":"Global developmental delay","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5681,"phenoTypeName":"Hip dysplasia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":4724,"phenoTypeName":"Hip osteoarthritis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14144,"phenoTypeName":"Hyperactivity","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":6236,"phenoTypeName":"Muscle stiffness","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10138,"phenoTypeName":"Nyctalopia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10124,"phenoTypeName":"Optic atrophy","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10435,"phenoTypeName":"Otosclerosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9348,"phenoTypeName":"Papilledema","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10411,"phenoTypeName":"Prominent supraorbital ridges","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13850,"phenoTypeName":"Spinal cord compression","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":15430,"phenoTypeName":"Temporomandibular joint ankylosis","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10722,"phenoTypeName":"Upper airway obstruction","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":10447,"phenoTypeName":"Wide nasal bridge","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":5715,"phenoTypeName":"Wide nose","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":7780,"phenoTypeName":"Abnormal temper tantrums","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":6013,"phenoTypeName":"Aggressive behavior","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":11774,"phenoTypeName":"Arrhythmia","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":6027,"phenoTypeName":"Hypertension","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":11798,"phenoTypeName":"Impulsivity","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":3032,"phenoTypeName":"Large central visual field defect","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":5131,"phenoTypeName":"Oppositional defiant disorder","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":9081,"phenoTypeName":"Peripheral arterial stenosis","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":6026,"phenoTypeName":"Stereotypy","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":8980,"phenoTypeName":"Abnormal heart valve morphology","percentRanges":"-"},{"phenoTypeId":13731,"phenoTypeName":"Asthma","percentRanges":"-"},{"phenoTypeId":11422,"phenoTypeName":"Cervical cord compression","percentRanges":"-"},{"phenoTypeId":4779,"phenoTypeName":"Congestive heart failure","percentRanges":"-"},{"phenoTypeId":12618,"phenoTypeName":"Delayed eruption of teeth","percentRanges":"-"},{"phenoTypeId":15606,"phenoTypeName":"Dermatan sulfate excretion in urine","percentRanges":"-"},{"phenoTypeId":13401,"phenoTypeName":"Diarrhea","percentRanges":"-"},{"phenoTypeId":9864,"phenoTypeName":"Dolichocephaly","percentRanges":"-"},{"phenoTypeId":5672,"phenoTypeName":"Flexion contracture","percentRanges":"-"},{"phenoTypeId":11303,"phenoTypeName":"Hearing impairment","percentRanges":"-"},{"phenoTypeId":13754,"phenoTypeName":"Heparan sulfate excretion in urine","percentRanges":"-"},{"phenoTypeId":9825,"phenoTypeName":"Hydrocephalus","percentRanges":"-"},{"phenoTypeId":8278,"phenoTypeName":"Hypertrichosis","percentRanges":"-"},{"phenoTypeId":13859,"phenoTypeName":"Intellectual disability, profound","percentRanges":"-"},{"phenoTypeId":10342,"phenoTypeName":"Intestinal pseudo-obstruction","percentRanges":"-"},{"phenoTypeId":7902,"phenoTypeName":"Kyphosis","percentRanges":"-"},{"phenoTypeId":13611,"phenoTypeName":"Mild short stature","percentRanges":"-"},{"phenoTypeId":13851,"phenoTypeName":"Neurodegeneration","percentRanges":"-"},{"phenoTypeId":7960,"phenoTypeName":"Obstructive sleep apnea","percentRanges":"-"},{"phenoTypeId":3896,"phenoTypeName":"Pes cavus","percentRanges":"-"},{"phenoTypeId":5615,"phenoTypeName":"Ptosis","percentRanges":"-"},{"phenoTypeId":11334,"phenoTypeName":"Recurrent otitis media","percentRanges":"-"},{"phenoTypeId":2329,"phenoTypeName":"Scaphocephaly","percentRanges":"-"},{"phenoTypeId":13617,"phenoTypeName":"Severe short stature","percentRanges":"-"},{"phenoTypeId":10472,"phenoTypeName":"Short neck","percentRanges":"-"},{"phenoTypeId":3066,"phenoTypeName":"Split hand","percentRanges":"-"},{"phenoTypeId":9781,"phenoTypeName":"Thick lower lip vermilion","percentRanges":"-"},{"phenoTypeId":10724,"phenoTypeName":"Tracheobronchomalacia","percentRanges":"-"},{"phenoTypeId":6227,"phenoTypeName":"Urinary glycosaminoglycan excretion","percentRanges":"-"},{"phenoTypeId":12622,"phenoTypeName":"Widely spaced teeth","percentRanges":"-"},{"phenoTypeId":5707,"phenoTypeName":"X-linked recessive inheritance","percentRanges":"-"}],"medicalProducts":[{"productId":442,"genericName":"Idursulfase","tradeName":"Elaprase®","tradeLink":"http://www.elaprase.com/","manufacturer":"Shire","sponsor":"Shire Human Genetic Therapies, Inc.","indication":"Indicated for patients with Hunter syndrome (mucopolysaccharidosis II, MPS II).  Idursulfase has been shown to improve walking capacity in these patients","drugInformationLink":"http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=Elaprase","medlinePlusLink":""}],"EncodedName":"Mucopolysaccharidosis_type_II"}